Bajaj Healthcare Limited

Fund Raising Details

  • On September 19, 2024, the company allotted 39,84,852 Equity Shares and 20,79,409 Convertible Warrants, raising an aggregate amount of ₹15,225.90 Lakhs
  • This included 25% of the warrant issue price (₹1,757.10 Lakhs) received at the time of allotment of Convertible Warrants
  • During Q4 FY26 (quarter ended March 31, 2026), the company received the balance 75% of the warrant issue price aggregating ₹5,271.30 Lakhs

Warrant Conversion and Capital Impact

  • Board of Directors approved conversion of all 20,79,409 Convertible Warrants into equity shares at their meeting on March 18, 2026
  • Post-conversion, the issued, subscribed, and paid-up equity share capital increased from ₹15,79,16,260 (3,15,83,252 equity shares of ₹5 each) to ₹16,83,13,305 (3,36,62,661 equity shares of ₹5 each)
  • During Q1 FY27 (quarter ended June 30, 2026), the company received approvals from NSE and BSE for listing and trading of the 20,79,409 new equity shares

Fund Utilization Status

| Purpose | Original Allocation (₹ Lakhs) | Modified Allocation (₹ Lakhs) | Funds Utilized (₹ Lakhs) | Deviation |

| Repayment & Prepayment of Secured/Unsecured Loans from Bank/NBFC | 15,000.00 | 15,000.00 | 15,000.00 | NIL |

| Investment in Capital Expenditure | 3,500.00 | 3,500.00 | 2,330.84 | NIL |

| General Corporate Purpose | 2,200.00 | 1,997.00 | 1,993.48 | NIL |

| Total | 20,700.00 | 20,497.00 | 19,324.32 | NIL |

Signatories and Authentication

  • Digitally signed by Monica Tanwar, Company Secretary & Compliance Officer on July 20, 2026
  • Statement also certified by Rohan Parekh, Chief Financial Officer